Vanberra Signal

Atrility Medical

Curated by Signal

Device for atrial arrhythmia diagnosis

Overview

Atrility Medical is developing a device for atrial arrhythmia diagnosis. The device offers electrocardiogram technology for continuous monitoring of the atrial arrhythmia in post-operative patient. The product is not yet approved by FDA as of May 2018.

Key facts

Founded
2017

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of an AI-enabled platform for the detection of disease-specific biomarkers

    Life Sciences TechnologyMilton, United States
  • Provider of blood pressure monitoring devices

    Life Sciences TechnologyLos Angeles, United States

About Atrility Medical

What does Atrility Medical do?

Atrility Medical is developing a device for atrial arrhythmia diagnosis.

Where is Atrility Medical headquartered?

Atrility Medical is headquartered in Madison, United States.

When was Atrility Medical founded?

Atrility Medical was founded in 2017.

Which sector is Atrility Medical in?

Atrility Medical operates in Life Sciences Technology.

Who are Atrility Medical's competitors?

Companies similar to Atrility Medical include Constant Care Technology, Know Biological, and Omedderic.